General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Apple(SIGNIFICANT), Novartis Corporation(MODEST), Genentech, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Blackstone Life Sciences(MODEST), TenSixteen Bio(SIGNIFICANT), Allelica(MODEST), GV (formerly Google Ventures)(MODEST), Esperion Therapeutics(SIGNIFICANT), Magnet Biomedicine(MODEST), Foresite Capital(MODEST), CRISPR Therapeutics(MODEST), HeartFlow(MODEST), Eli Lilly and Company(MODEST), Merck & Co., Inc.(MODEST), Foresite Labs(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Bain Capital(MODEST), Bristol-Myers Squibb Company (MODEST), Eli Lilly and Company(MODEST), Tourmaline Bio(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Vertex Pharmaceuticals(SIGNIFICANT), TenSixteen Bio(SIGNIFICANT), Preciseli(MODEST), Parameter Health(MODEST), Bolt(MODEST), Mercury(MODEST), Candela(MODEST), MyOme(MODEST) RESEARCH/RESEARCH GRANTS: Amgen Inc.(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Boston Scientific(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Apple(SIGNIFICANT), Allelica(SIGNIFICANT) SALARY: Vertex Pharmaceuticals(SIGNIFICANT)

View Full Disclosure